No-shpa solution for injections ampoules 20 mg/ml. 2 ml. №5

Description

No-shpa composition
The main active ingredient is drotaverine hydrochloride, it also has additional substances.

Release form
It is produced in the form of an injection solution, poured into glass ampoules.

Pharmacological properties
By lowering the tone of the smooth muscles of the abdominal organs, No-shpa is able to reduce their motor activity, while slightly expanding the blood vessels. More effective than papaverine. Does not affect the autonomic nervous and central nervous systems.

Indications
Scope of application: gastric, intestinal spasms caused by spasms of smooth muscles, which can occur with spastic constipation, gallstone and urolithiasis, angina pectoris, headaches of tension spasm of the peripheral vessels, diseases of the biliary tract (papillitis, cholecystolithiasis, holocholecystitis ), gastrointestinal tract (stomach ulcer, duodenal ulcer, spastic colitis, gastritis, enteritis, colitis). It is also prescribed for diseases of the urinary system, in which smooth muscles spasm – nephrolithiasis, urethrolithiasis, cystitis, pyelitis, tenesmus of the bladder, pain in gynecology, including painful menstrual pain.

Contraindications
Contraindicated if the patient has a hypertrophied prostate gland, glaucoma (angle-closure). It is not used for severe renal, hepatic or heart failure, an allergic reaction to drotaverine or excipients (lactose).

Application during pregnancy and lactation
It is used with great care. At childbirth, it is prescribed and used only by medical workers, in a hospital setting.

Method of administration and dosage
For intramuscular or intravenous administration, 2 or 4 milliliters of a 2 percent No-shpa solution are injected. With obliterating endarteritis or inflammation of the inner lining of the arteries of the extremities, accompanied by a narrowing of the lumen in them, intra-arterial administration is permissible.
During childbirth, it is used in order to shorten the phase of cervical dilatation, while 40 milligrams are injected intramuscularly, if necessary, repetition is permissible within the next two hours.

Overdose
In case of an overdose, symptoms of heart rhythm disturbances, myocardial conduction, up to death are observed. Treatment is symptomatic.

Side effects
As side effects, symptoms of dyspeptic disorders, allergic dermatitis, disorders of the immune system can be observed, tachycardia may develop, a drop in blood pressure.

Storage conditions and periods
No-shpa is stored for up to 3 years at temperatures up to 25 ° C.